As a long-established manufacturer and supplier of medical products, the health and safety of our customers and staff has always been paramount for Gel Ovations Europe.
In all our operations, our manufacturing facilities, offices, packing and shipment, hygiene, sanitising and constant cleaning remains at the highest level at all times.
Additionally, we are following all government and WHO and public health guidelines for personal and building hygiene at our premises, to ensure your health and safety at all times.
In our manufacturing and shipping facilities, staff have received the latest training in correct personal hygiene and sanitization in line with government, WHO and Public Health England advice to ensure that our products are not contaminated with Coronavirus.
This reassurance also extends to our shipping partners. We send all our products to customers by
UK Mail which is part of the DHL Group. They have confirmed that there is no evidence that an infection with any type of Coronavirus is possible through contact with objects or packages, including those arriving from areas where cases have been reported (source: WHO, Robert Koch institute).
This is also confirmed by Public Health England (PHE), and The Royal Mail which state that people receiving parcels are not at risk of contracting the coronavirus.
In addition, although the virus can remain active and contagious in the human body for weeks, it can only live on surfaces for a few hours. According to The Centers for Disease Control and Prevention (CDC) confirms that as with all viruses, the Coronavirus cannot live long outside the body and only has a lifespan in a range of hours. As a result the Gel Ovations products you receive are immediately safe to use.
As a business operating in the healthcare sector, we have long-established business continuity planning in place to ensure that service to customer service and delivery times are not affected by events including the Coronavirus epidemic and these plans are now in place for your peace of mind.
We are monitoring the latest developments on a constant basis and will update this page accordingly.
For further information please contact us at:
tel: +44 (0)1454 285 071